Photo: mcw.edu
Feb 1, 2026, 11:32
Qizhen Shi։ A Padua Moment for Factor VIII Gene Therapy
Qizhen Shi, Professor at Medical College of Wisconsin, Program Co-Leader of Thrombosis and Hemostasis at Versiti Blood Research Institute, shared on LinkedIn:
”Honored to share that my Blood Commentary, ‘A Padua moment for factor VIII gene therapy,’ has now been published.
The Commentary discusses a newly engineered FVIII variant with improved secretion and cofactor activity, offering a Padua-like advance for hemophilia A gene therapy by enabling efficacy at substantially lower vector doses.
Congratulations to the authors of the original study, and thank you to the Blood editorial team for the invitation.”
Stay updated with Hemostasis Today.
-
Feb 1, 2026, 11:25Abdul Mannan: Breaking Down the New BSH Hepatitis Guideline for Haemophilia Nurses
-
Feb 1, 2026, 11:24Nathan Wong on Economic Benefits of Inclisiran for LDL-C Control
-
Feb 1, 2026, 11:10Antonio Ciacciarelli Shares A Comparison of Pragmatic Post-Thrombectomy Prognostic Scores
-
Feb 1, 2026, 10:41Colm Dougan on The Blood Infection That Changed Medicine
-
Feb 1, 2026, 10:25Indunil Karunarathna Breaks Down The Cerebral Venous Sinus Thrombosis
-
Feb 1, 2026, 10:14Jesse Solar Explains Pulmonary Embolism
-
Feb 1, 2026, 09:56Toni Lassila on Computational Models for Predicting Thrombus Formation
-
Feb 1, 2026, 09:45Nour Al-Mozain Contributs to 12th Edition of the Cell Therapy Standard and Global Transfusion Education
-
Feb 1, 2026, 09:26New Insights on Hypertriglyceridemia, Atherosclerosis, and Future Strategies to Reduce Cardiovascular Risk – EAS